We are live on ! Find out more
ACIU icon

AC Immune
ACIU

41 hedge funds and large institutions have $90.6M invested in AC Immune in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 6

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

5% more funds holding

Funds holding: 39 → 41 (+2)

3.52% less ownership

Funds ownership: 30.06% → 26.54% (-3.5%)

53% less capital invested

Capital invested by funds: $191M → $90.6M (-$101M)

Holders
41
Holders Change
+2
Holders Change %
+5.13%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
14
Reduced
6
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$33.2M
2
PM
Prosight Management
Texas
+$4.52M
3
AG
Artal Group
Luxembourg
+$1.59M
4
Artisan Partners
Artisan Partners
Wisconsin
+$1.14M
5
Millennium Management
Millennium Management
New York
+$1.08M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$22.4M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$14.9M
3
O
OrbiMed
New York
-$13.6M
4
DFO
Duquesne Family Office
New York
-$7.42M
5
Marshall Wace
Marshall Wace
United Kingdom
-$4.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$37.6M +$33.2M +5,225,507 +234%
Temasek Holdings
2
Temasek Holdings
Singapore
$13.2M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$10.5M -$22.4M -3,526,664 -63%
DFO
4
Duquesne Family Office
New York
$6.69M -$7.42M -1,166,582 -47%
AG
5
Artal Group
Luxembourg
$5.05M +$1.59M +250,000 +33%
PM
6
Prosight Management
Texas
$3.59M +$4.52M +710,541 New
BlackRock
7
BlackRock
New York
$3.52M +$339K +53,327 +8%
Renaissance Technologies
8
Renaissance Technologies
New York
$1.11M +$956K +150,350 +215%
Artisan Partners
9
Artisan Partners
Wisconsin
$903K +$1.14M +178,866 New
TCM
10
Tekla Capital Management
Massachusetts
$868K – – –
Millennium Management
11
Millennium Management
New York
$857K +$1.08M +169,759 New
AA
12
ALPS Advisors
Colorado
$822K +$44.7K +7,029 +5%
Citadel Advisors
13
Citadel Advisors
Florida
$626K -$2.07M -325,525 -72%
Wells Fargo
14
Wells Fargo
California
$604K +$761K +119,694 New
BFM
15
Boothbay Fund Management
New York
$477K +$446K +70,124 +288%
Deutsche Bank
16
Deutsche Bank
Germany
$468K +$591K +92,962 New
VF
17
Virtu Financial
New York
$397K +$500K +78,569 New
State of New Jersey Common Pension Fund D
18
State of New Jersey Common Pension Fund D
New Jersey
$395K – – –
Morgan Stanley
19
Morgan Stanley
New York
$362K +$276K +43,468 +154%
ARTA
20
A.R.T. Advisors
New York
$279K +$230K +36,201 +190%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$268K +$5.92K +930 +2%
PC
22
PA Capital
Virginia
$202K +$255K +40,055 New
OPPM
23
Opus Point Partners Management
New York
$201K +$253K +39,801 New
CLOS
24
Compagnie Lombard Odier SCmA
Switzerland
$180K +$68.1K +10,700 +43%
ECM
25
Element Capital Management
New York
$167K +$211K +33,102 New
1
2 3

ACIU Hedge Fund Activity: Q1 2019 in Review

41 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q1 2019, worth a combined $90.6M — down 53% from $191M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ACIU positions and 14 closed out — a net gain of 2 holders — while 14 added to existing stakes and 6 trimmed.

The largest buyer was BVF Inc, adding an estimated $33.2M. The largest seller was Fidelity Investments, cutting an estimated $22.4M.

  • 41 institutional investors held AC Immune (ACIU) as of Q1 2019, up from 39 in Q4 2018.
  • Funds reported $90.6M of AC Immune stock for Q1 2019, down 53% quarter-over-quarter.
  • 16 funds opened new AC Immune positions in Q1 2019 and 14 closed out, a net change of +2 holders.
  • The largest AC Immune buyer in Q1 2019 was BVF Inc, an estimated $33.2M added.
  • The largest AC Immune seller in Q1 2019 was Fidelity Investments, an estimated $22.4M sold.

Based on aggregated 13F filings for Q1 2019.